| Primary information |
|---|
| sequence ID | Seq_2355 |
| Peptide sequence | FQTVTDYGKDLMEKV |
| CancerPDF_ID | CancerPDF_ID5013, CancerPDF_ID8843, |
| PMID | 24982608,24694173 |
| Protein Name | Apolipoprotein A-II,Apolipoprotein A-II |
| UniprotKB Entry Name | APOA2_HUMAN,APOA2_HUMAN |
| Fluid | Urine,Ascites fluid |
| M/Z | NA,NA |
| Charge | NA,1 |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | Nano-LC-MS,LTQ-Orbitrap XL |
| Peptide Identification technique | MS/MS,X tandem for peptide identification |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | 0.01,NA |
| CancerPDF_ID | CancerPDF_ID5013, CancerPDF_ID8843, |
| p-Value | NA,NA |
| Software | "GPM search engine, MASCOT","X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
| Length | 15,15 |
| Cancer Type | Ovarian cancer,Ovarian cancer |
| Database | IPI 3.71 Human Database ,IPI00021854 |
| Modification | NA,NA |
| Number of Patients | 6 Ovarian cancer patients and 6 normal individuals,3 ovarian cancer patient and 3 non cancerous control |
| Regulation | Uniquely present in case of urine of ovarian cancer patients,Uniquely expressed in ovarian cancer patient |
| Validation | NA,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |